Total Payments
$89,146
2024 Payments
$10,475
Companies
10
Transactions
110
Medicare Patients
1,540
Medicare Billing
$228,807
Payment Breakdown by Category
Other$59,937 (67.2%)
Travel$16,689 (18.7%)
Consulting$9,090 (10.2%)
Food & Beverage$3,429 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,937 | 23 | 67.2% |
| Travel and Lodging | $16,689 | 37 | 18.7% |
| Consulting Fee | $9,090 | 3 | 10.2% |
| Food and Beverage | $3,429 | 47 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $77,097 | 87 | $0 (2020) |
| SpringWorks Therapeutics, Inc. | $10,287 | 4 | $0 (2024) |
| Amgen Inc. | $694.89 | 2 | $0 (2018) |
| Covidien LP | $485.85 | 10 | $0 (2020) |
| Medtronic, Inc. | $225.96 | 2 | $0 (2023) |
| INTUITIVE SURGICAL, INC. | $121.55 | 1 | $0 (2024) |
| TESARO, Inc. | $99.76 | 1 | $0 (2017) |
| Iovance Biotherapeutics, Inc. | $65.93 | 1 | $0 (2024) |
| Heron Therapeutics, Inc. | $51.26 | 1 | $0 (2022) |
| Midatech Pharma US Inc | $16.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,475 | 6 | SpringWorks Therapeutics, Inc. ($10,287) |
| 2023 | $131.84 | 1 | Medtronic, Inc. ($131.84) |
| 2022 | $145.38 | 2 | Medtronic, Inc. ($94.12) |
| 2020 | $6,543 | 4 | Novartis Pharmaceuticals Corporation ($6,390) |
| 2019 | $20,738 | 22 | Novartis Pharmaceuticals Corporation ($20,695) |
| 2018 | $50,814 | 69 | Novartis Pharmaceuticals Corporation ($49,914) |
| 2017 | $298.57 | 6 | TESARO, Inc. ($99.76) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $121.55 | General |
| Category: SURGERY | ||||||
| 06/26/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,640.00 | General |
| Category: DESMOID TUMORS | ||||||
| 04/03/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,715.00 | General |
| Category: DESMOID TUMORS | ||||||
| 03/16/2024 | Iovance Biotherapeutics, Inc. | Amtagvi (Drug) | Food and Beverage | Cash or cash equivalent | $65.93 | General |
| Category: Oncology | ||||||
| 03/14/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $410.00 | General |
| Category: DESMOID TUMORS | ||||||
| 02/07/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,522.47 | General |
| Category: DESMOID TUMORS | ||||||
| 02/28/2023 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $131.84 | General |
| 06/28/2022 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $94.12 | General |
| 06/03/2022 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $51.26 | General |
| Category: Postoperative Pain | ||||||
| 09/10/2020 | Covidien LP | Endo GIA (Device) | Food and Beverage | In-kind items and services | $91.05 | General |
| Category: Surgical Stapling | ||||||
| 07/31/2020 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Consulting Fee | Cash or cash equivalent | $4,260.00 | General |
| Category: ONCOLOGY | ||||||
| 02/13/2020 | Covidien LP | Endo GIA (Device) | Food and Beverage | In-kind items and services | $61.59 | General |
| Category: Surgical Stapling | ||||||
| 01/27/2020 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Consulting Fee | Cash or cash equivalent | $2,130.00 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $752.56 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $56.34 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $624.14 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $71.70 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $1,480.02 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | In-kind items and services | $316.07 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | In-kind items and services | $261.22 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $86.23 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | Cash or cash equivalent | $11.06 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 390 | 403 | $382,537 | $55,654 |
| 2022 | 10 | 350 | 371 | $320,904 | $50,437 |
| 2021 | 11 | 416 | 437 | $409,438 | $64,954 |
| 2020 | 11 | 384 | 401 | $380,204 | $57,762 |
Total Patients
1,540
Total Services
1,612
Medicare Billing
$228,807
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Facility | 2023 | 52 | 56 | $108,248 | $11,554 | 10.7% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2023 | 28 | 28 | $60,726 | $10,911 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 84 | $27,132 | $7,549 | 27.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 109 | 109 | $31,725 | $6,011 | 18.9% |
| 38510 | Biopsy or removal of deep lymph nodes of neck | Facility | 2023 | 16 | 16 | $36,261 | $5,563 | 15.3% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 36 | 36 | $30,240 | $4,460 | 14.7% |
| 38531 | Biopsy or removal of lymph nodes of groin | Facility | 2023 | 11 | 11 | $27,709 | $4,414 | 15.9% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Facility | 2023 | 32 | 32 | $51,808 | $2,803 | 5.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $4,746 | $1,200 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $3,942 | $1,189 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 127 | $41,021 | $12,226 | 29.8% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2022 | 23 | 23 | $52,350 | $9,543 | 18.2% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Facility | 2022 | 43 | 48 | $92,784 | $9,394 | 10.1% |
| 38531 | Biopsy or removal of lymph nodes of groin | Facility | 2022 | 14 | 14 | $35,266 | $5,718 | 16.2% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 36 | 36 | $31,080 | $4,604 | 14.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 67 | 67 | $19,683 | $4,009 | 20.4% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Facility | 2022 | 17 | 17 | $27,523 | $1,506 | 5.5% |
| 12035 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 12.6-20.0 cm | Facility | 2022 | 11 | 11 | $13,090 | $1,179 | 9.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $3,285 | $1,149 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,822 | $1,109 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 128 | $41,344 | $13,595 | 32.9% |
| 38525 | Biopsy or removal of lymph nodes of under the arm, open procedure | Facility | 2021 | 26 | 26 | $58,632 | $10,992 | 18.7% |
| 11606 | Removal of malignant growth (over 4.0 centimeters) of the trunk, arms, or legs | Facility | 2021 | 48 | 55 | $106,315 | $10,794 | 10.2% |
| 38531 | Open biopsy or excision of lymph nodes in groin | Facility | 2021 | 15 | 15 | $40,304 | $6,386 | 15.8% |
| 38510 | Biopsy or removal of lymph nodes of neck, open procedure | Facility | 2021 | 15 | 15 | $34,128 | $5,929 | 17.4% |
About Dr. Jeffrey Wayne, MD
Dr. Jeffrey Wayne, MD is a Surgical Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417973116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Wayne, MD has received a total of $89,146 in payments from pharmaceutical and medical device companies, with $10,475 received in 2024. These payments were reported across 110 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,937).
As a Medicare-enrolled provider, Wayne has provided services to 1,540 Medicare beneficiaries, totaling 1,612 services with total Medicare billing of $228,807. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Oncology
- Location Chicago, IL
- Active Since 07/14/2006
- Last Updated 07/12/2007
- Taxonomy Code 2086X0206X
- Entity Type Individual
- NPI Number 1417973116
Products in Payments
- MEKINIST (Drug) $76,970
- OGSIVEO (Drug) $10,287
- IMLYGIC (Biological) $694.89
- Endo GIA (Device) $269.49
- LigaSure (Device) $127.77
- VOTRIENT (Drug) $127.35
- Da Vinci Surgical System (Device) $121.55
- ZEJULA (Drug) $99.76
- Emprint (Device) $79.63
- Amtagvi (Drug) $65.93
- Zynrelef (Drug) $51.26
- Gelclair (Device) $16.05
- Valleylab (Device) $8.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Oncology Doctors in Chicago
Dr. Steven Gitelis, M.d, M.D
Surgical Oncology — Payments: $426,281
Surgical Oncology $426,281
Dr. Fadi Dahdaleh, M.d, M.D
Surgical Oncology — Payments: $188,606
Surgical Oncology $188,606
Nora Hansen, Md, MD
Surgical Oncology — Payments: $81,010
Surgical Oncology $81,010
Dr. Alan Blank, M.d, M.D
Surgical Oncology — Payments: $71,104
Surgical Oncology $71,104
David Bentrem, Md, MD
Surgical Oncology — Payments: $35,268
Surgical Oncology $35,268
James Millis
Surgical Oncology — Payments: $33,326
Surgical Oncology $33,326